• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Factors influencing antipyrine elimination.影响安替比林消除的因素。
Br J Clin Pharmacol. 1977 Jun;4(3):261-5. doi: 10.1111/j.1365-2125.1977.tb00710.x.
2
Antipyrine kinetics in liver disease and liver transplantation.肝病及肝移植中的安替比林动力学
Clin Pharmacol Ther. 1986 Apr;39(4):372-7. doi: 10.1038/clpt.1986.57.
3
Assessment of antipyrine kinetics by measurement in saliva.通过唾液测量评估安替比林动力学。
Br J Clin Pharmacol. 1976 Apr;3(2):321-5. doi: 10.1111/j.1365-2125.1976.tb00610.x.
4
Salivary antipyrine half-life: a useful measure of hepatic drug metabolism.唾液中安替比林半衰期：肝脏药物代谢的一项有用指标。
Br J Clin Pharmacol. 1976 Oct;3(5):945-6. doi: 10.1111/j.1365-2125.1976.tb00656.x.
5
Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
Aust N Z J Med. 1977 Aug;7(4):385-90. doi: 10.1111/j.1445-5994.1977.tb04401.x.
6
Saliva and plasma clearance of antipyrine as reflectors of liver function.安替比林的唾液和血浆清除率作为肝功能的反映指标。
Eur J Drug Metab Pharmacokinet. 1981;6(4):261-4. doi: 10.1007/BF03189523.
7
Elimination of antipyrine from saliva as a measure of metabolism in man.通过测定唾液中安替比林的消除情况来衡量人体新陈代谢。
Clin Pharmacol Ther. 1975 Sep;18(3):249-58. doi: 10.1002/cpt1975183249.
8
Iron deficiency anaemia and drug metabolism.
J Pharm Pharmacol. 1973 Apr;25(4):339-40. doi: 10.1111/j.2042-7158.1973.tb10020.x.
9
Altered plasma half-lives of antipyrine, propylthiouracil, and methimazole in thyroid dysfunction.甲状腺功能障碍时安替比林、丙硫氧嘧啶和甲巯咪唑的血浆半衰期改变。
Clin Pharmacol Ther. 1975 Jan;17(1):48-56. doi: 10.1002/cpt197517148.
10
Impairment of drug elimination in patients with liver disease.肝病患者药物消除功能受损。
Int J Clin Pharmacol Ther Toxicol. 1985 Jan;23(1):28-32.

引用本文的文献

1
Chitosan Nanoparticles: Approaches to Preparation, Key Properties, Drug Delivery Systems, and Developments in Therapeutic Efficacy.壳聚糖纳米颗粒：制备方法、关键特性、药物递送系统及治疗效果的进展
AAPS PharmSciTech. 2025 Apr 17;26(5):108. doi: 10.1208/s12249-025-03100-z.
2
The Influence of Drugs Solubilities and Chitosan-TPP Formulation Parameters on the Mean Hydrodynamic Diameters and Drugs Entrapment Efficiencies into Chitosan-TPP Nanoparticles.药物溶解度和壳聚糖-TPP 制剂参数对壳聚糖-TPP 纳米粒子平均水动力学直径和药物包封效率的影响。
AAPS PharmSciTech. 2022 Sep 22;23(7):262. doi: 10.1208/s12249-022-02420-8.
3
Effects of dipyrone on the digestive tract.安乃近对消化道的影响。
Braz J Med Biol Res. 2019 Jan 10;52(2):e8103. doi: 10.1590/1414-431X20188103.
4
Development of a physiologically-based pharmacokinetic model of the rat central nervous system.大鼠中枢神经系统生理基于模型的药代动力学模型的开发。
Pharmaceutics. 2014 Mar 18;6(1):97-136. doi: 10.3390/pharmaceutics6010097.
5
Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation.口服劳拉西泮在人体中的单剂量和多剂量动力学：蓄积的可预测性。
J Pharmacokinet Biopharm. 1979 Apr;7(2):159-79. doi: 10.1007/BF01059736.
6
Effect of erythrocytes on the hepatic distribution kinetics of antipyrine.红细胞对安替比林肝脏分布动力学的影响。
Eur J Drug Metab Pharmacokinet. 2004 Jan-Mar;29(1):37-41. doi: 10.1007/BF03190572.
7
Induction of microsomal drug metabolism in man and in the rat by exposure to petroleum.通过接触石油诱导人和大鼠微粒体药物代谢。
Br J Ind Med. 1981 Feb;38(1):91-7. doi: 10.1136/oem.38.1.91.
8
A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs.正常受试者及接受酶诱导药物治疗患者中安替比林和利多卡因处置的比较研究。
Br J Clin Pharmacol. 1980 Nov;10(5):491-7. doi: 10.1111/j.1365-2125.1980.tb01794.x.
9
The effects of age and smoking upon antipyrine metabolism.年龄和吸烟对安替比林代谢的影响。
Br J Clin Pharmacol. 1980 Jun;9(6):613-4. doi: 10.1111/j.1365-2125.1980.tb01089.x.
10
Antipyrine elimination by patients under treatment with monoamine oxidase inhibitors.接受单胺氧化酶抑制剂治疗的患者的安替比林消除情况。
Br J Clin Pharmacol. 1980 Jan;9(1):21-5. doi: 10.1111/j.1365-2125.1980.tb04791.x.

本文引用的文献

1
The fate of antipyrine in man.安替比林在人体内的代谢情况。
J Pharmacol Exp Ther. 1950 Jan;98(1):97-104.
2
Effect of environmental factors on drug metabolism: decreased plasma half-life of antipyrine in workers exposed to chlorinated hydrocarbon insecticides.环境因素对药物代谢的影响：接触氯代烃类杀虫剂的工人中安替比林的血浆半衰期缩短。
Clin Pharmacol Ther. 1969 Sep-Oct;10(5):638-42. doi: 10.1002/cpt1969105638.
3
Genetic control of drug levels in man: antipyrine.人体药物水平的遗传控制：安替比林
Science. 1968 Jul 5;161(3836):72-3. doi: 10.1126/science.161.3836.72.
4
Metabolism of drugs. LIX. A new metabolite of antipyrine.药物代谢。第五十九篇。安替比林的一种新代谢物。
Biochem Pharmacol. 1968 Aug;17(8):1511-6. doi: 10.1016/0006-2952(68)90210-4.
5
Effect of age and sex on human drug metabolism.年龄和性别对人体药物代谢的影响。
Br Med J. 1971 Sep 11;3(5775):607-9. doi: 10.1136/bmj.3.5775.607.
6
Drug-metabolizing capacity in states of drug dependence and withdrawal.药物依赖和戒断状态下的药物代谢能力。
Br J Pharmacol. 1972 Aug;45(4):638-43. doi: 10.1111/j.1476-5381.1972.tb08122.x.
7
Impairment of human drug metabolism by oral contraceptive steroids.口服避孕类固醇对人体药物代谢的损害。
Clin Pharmacol Ther. 1972 Jul-Aug;13(4):552-7. doi: 10.1002/cpt1972134552.
8
Correlation of the plasma elimination of antipyrine and the appearance of 4-hydroxy antipyrine in the urine of man.人体尿液中安替比林的血浆消除与4-羟基安替比林出现的相关性。
Biochem Pharmacol. 1974 Jan 15;23(2):197-201. doi: 10.1016/0006-2952(74)90410-9.
9
Proceedings: Changes in drug metabolizing ability in thyroid disease.会议论文：甲状腺疾病中药物代谢能力的变化
Br J Pharmacol. 1973 Sep;49(1):156P-157P.
10
Stimulation of drug metabolism in man by tricyclic antidepressants.三环类抗抑郁药对人体药物代谢的刺激作用。
Eur J Clin Pharmacol. 1973 Aug;6(2):102-6. doi: 10.1007/BF00562435.

Factors influencing antipyrine elimination.

作者信息

Stevenson I H

出版信息

Br J Clin Pharmacol. 1977 Jun;4(3):261-5. doi: 10.1111/j.1365-2125.1977.tb00710.x.

DOI:10.1111/j.1365-2125.1977.tb00710.x
PMID:332216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1429089/
Abstract
摘要